VEGFA and hepatocellular carcinoma: However, following TACE therapy, the tumor is exposed to hypoxia, which increases the risk of HCC recurrence and metastasis by upregulating the expression of vascular endothelial growth factor, tumor revascularization, and local recurrence [20].